QIAGEN N.V. to release results for Q4 2023 and hold webcast

Rhea-AI Summary

QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) plans to release results for the fourth quarter and full year 2023 on Tuesday, February 6, after 22:05 Frankfurt time. The conference call is scheduled for Wednesday, February 7, at 15:00 Frankfurt time. Investors and analysts can join the call through various options, including call back connection, dial-in by phone, and access to the audio webcast.

Venlo, The Netherlands, Jan. 11, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced plans to release results for the fourth quarter and full year 2023.

Press release date/time: Tuesday, February 6, shortly after 22:05 Frankfurt time / 21:05 London time / 16:05 New York time.

Conference call date/time: Wednesday, February 7, at 15:00 Frankfurt time / 14:00 London time / 09:00 New York time. 

Three options for joining the conference call

1. Register for call back connection - Click here: Connect me

Service is available 15 minutes before the call starts 

1. Dial-in by phone

U.S.: +1 646 828 8193
UK: +44 (0)330 165 3655
GER: +49 (0)69 6610 2492
Conference ID: 2206067
To avoid waiting time, please join the event conference 5-10 minutes prior to the start time. 

1. Access the audio webcast - Click here: Access Webcast 

A conference call replay will be available by using the following link:
https://event.webcasts.com/starthere.jsp?ei=1643464&tp_key=a2e231b651

Contact: IR@qiagen.com

About QIAGEN

QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to
Insight solutions that enable customers to gain valuable molecular insights from samples containing
the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from
blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for
analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable 
insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN
provides solutions to more than 500,000 customers around the world in Molecular Diagnostics
(human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics).
As of September 30, 2023, QIAGEN employed more than 6,000 people in over 35 locations worldwide.  
Further information can be found at http://www.qiagen.com.

source: QIAGEN N.V. 
category: Financial

FAQ

When will QIAGEN N.V. release results for the fourth quarter and full year 2023?

QIAGEN N.V. will release the results on Tuesday, February 6, after 22:05 Frankfurt time.

When is the conference call scheduled for QIAGEN N.V.?

The conference call is scheduled for Wednesday, February 7, at 15:00 Frankfurt time.

How can investors and analysts join the conference call for QIAGEN N.V.?

Investors and analysts can join the call through various options, including call back connection, dial-in by phone, and access to the audio webcast.